<PubmedArticle>
<MedlineCitation IndexingMethod="Curated" Owner="NLM" Status="MEDLINE">
<PMID Version="1">25827507</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1573-2517</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>178</Volume>
<PubDate>
<Year>2015</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Journal of affective disorders</Title>
<ISOAbbreviation>J Affect Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>An exploratory study of responses to low-dose lithium in African Americans and Hispanics.</ArticleTitle>
<Pagination>
<MedlinePgn>224-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2015.02.035</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0165-0327(15)00136-6</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Few prospective studies examine the impact of ethnicity or race on outcomes with lithium for bipolar disorder. This exploratory study examines differences in lithium response and treatment outcomes in Hispanics, African Americans, and non-Hispanic whites with bipolar disorder in the Lithium Treatment Moderate Dose Use Study (LiTMUS).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">LiTMUS was a six-site randomized controlled trial of low-dose lithium added to optimized treatment (OPT; personalized, evidence-based pharmacotherapy) vs. OPT alone in outpatients with bipolar disorder. Of 283 participants, 47 African Americans, 39 Hispanics, and 175 non-Hispanic whites were examined. We predicted minority groups would have more negative medication attitudes and higher attrition rates, but better clinical outcomes.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">African Americans in the lithium group improved more on depression and life functioning compared to whites over the 6 month study. African Americans in the OPT only group had marginal improvement on depression symptoms. For Hispanics, satisfaction with life did not significantly improve in the OPT only group, in contrast to whites and African Americans who improved over time on all measures. Attitudes toward medications did not differ across ethnic/racial groups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">African Americans show some greater improvements with lithium than non-Hispanic whites, and Hispanics showed more consistent improvements in the lithium group. The impact of low-dose lithium should be studied in a larger sample as there may be particular benefit for African Americans and Hispanics. Given that the control group (regardless of ethnicity/race) had significant improvements, optimized treatment may be beneficial for any ethnic group.</AbstractText>
<CopyrightInformation>Copyright Â© 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gonzalez Arnold</LastName>
<ForeName>Jodi</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Health Science Center San Antonio, USA. Electronic address: arnoldjg@uthscsa.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salcedo</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital - Bipolar Clinic and Research Program, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ketter</LastName>
<ForeName>Terrence A</ForeName>
<Initials>TA</Initials>
<AffiliationInfo>
<Affiliation>Stanford University School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Calabrese</LastName>
<ForeName>Joseph R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Case Western Reserve University, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rabideau</LastName>
<ForeName>Dustin J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital - Bipolar Clinic and Research Program, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nierenberg</LastName>
<ForeName>Andrew A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital - Bipolar Clinic and Research Program, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bazan</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Health Science Center San Antonio, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leon</LastName>
<ForeName>Andrew C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital - Bipolar Clinic and Research Program, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Friedman</LastName>
<ForeName>Edward S</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>University of Pittsburgh School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iosifescu</LastName>
<ForeName>Dan</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Mount Sinai School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sylvia</LastName>
<ForeName>Louisa G</ForeName>
<Initials>LG</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital - Bipolar Clinic and Research Program, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ostacher</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Stanford University School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thase</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>University of Pennsylvania School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reilly-Harrington</LastName>
<ForeName>Noreen A</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital - Bipolar Clinic and Research Program, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bowden</LastName>
<ForeName>Charles L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Health Science Center San Antonio, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>N01MH80001</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 MH086045</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>03</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Affect Disord</MedlineTA>
<NlmUniqueID>7906073</NlmUniqueID>
<ISSNLinking>0165-0327</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018020">Lithium Compounds</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001741">African Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018692">Antimanic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001290">Attitude</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001714">Bipolar Disorder</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044465">European Continental Ancestry Group</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006630">Hispanic Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018020">Lithium Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">African Americans</Keyword>
<Keyword MajorTopicYN="N">Bipolar disorder</Keyword>
<Keyword MajorTopicYN="N">Health disparities</Keyword>
<Keyword MajorTopicYN="N">Hispanics</Keyword>
<Keyword MajorTopicYN="N">Lithium</Keyword>
<Keyword MajorTopicYN="N">Treatment outcome</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>07</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>02</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25827507</ArticleId>
<ArticleId IdType="pii">S0165-0327(15)00136-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.jad.2015.02.035</ArticleId>
<ArticleId IdType="pmc">PMC4397978</ArticleId>
<ArticleId IdType="mid">NIHMS672139</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Nerv Ment Dis. 2000 Dec;188(12):805-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11191580</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Depress Anxiety. 2001;13(3):118-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11387731</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Care. 2003 Apr;41(4):479-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12665712</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Psychiatry. 1978 Nov;133:429-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">728692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Psychiatry. 1979 Apr;134:382-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">444788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Affect Disord. 1991 Aug;22(4):211-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1939930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacol Bull. 1993;29(2):321-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8290681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 1995 Mar 1;37(5):325-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7748984</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatry Res. 1997 Dec 5;73(3):159-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9481807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9881538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 2005 Jul;66(7):870-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16013903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychopharmacol. 2007 Apr;27(2):126-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17414234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Clin Psychol. 2005;1:113-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17716084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bipolar Disord. 2008 Mar;10(2):231-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18271901</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Womens Ment Health. 2008 Jun;11(2):93-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18463940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychopharmacol. 2009 Aug;29(4):358-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19593175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Trials. 2009 Aug;6(4):344-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19587069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatr Serv. 2009 Oct;60(10):1357-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19797376</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Trials. 2009 Dec;6(6):637-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19933719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatr Serv. 2010 Feb;61(2):164-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20123822</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Clin Psychopharmacol. 2011 May;26(3):141-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21164352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Schizophr Res. 2011 Aug;130(1-3):11-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21489754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2013 Jan;170(1):102-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23288387</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychol. 2013 Feb;69(2):115-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23280880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatr Serv. 2013 Jun;64(6):570-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23494108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Discov Med. 2013 Sep;16(87):113-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23998447</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>